Paradoxical reaction after switching between adalimumab biosimilars in a patient with psoriatic arthritis Mariano F. Palatnik, Emilce S. Fonseca, María Lorena Brance

A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch

Acquired Brown's Syndrome in a Patient With Psoriatic Arthritis Walter Alberto Sifuentes Giraldo, José Luis Morell Hita, Javier Bachiller Corral, Elia Brito Brito